Results
1 -
10 of
62TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts, Cancer Chemotherapy and Pharmacology AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts, Cancer Chemotherapy and Pharmacology Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study, Cancer Chemotherapy and Pharmacology Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma, Molecular Cancer Impact of Genetic Targets on Cancer Therapy in Acute Myelogenous Leukemia, Impact of Genetic Targets on Cancer Therapy Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasms, International Journal of Hematology Pathogenetic and clinical impact of JAK2 mutations in chronic myeloproliferative diseases, memo - Magazine of European Medical Oncology JAK2 Inhibitors for Therapy of Myeloproliferative Neoplasms, Myeloproliferative Neoplasms